Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05670015

Ocular Changes With Alpha-2 Receptor Agonist.

Conditions: Glaucoma, Suspect, Aberration, Corneal Wavefront

Sex: All

Ages: 18 Years – 50 Years

Phase: NA

Enrollment: 150

Sponsor: Benha University

Location: Egypt

Summary

selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.

Eligibility Criteria

Inclusion Criteria:Glaucoma suspect cases.post-refractive surgery cases.Exclusion Criteria:Cases with prostatic hyperplasia or diabetics that may alter the measurements of pupillary diameter.Cases with previous history of any retinal intervention or other drugs that may alter intraocular pressure measurements.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05670015). StuddyBuddy aggregates publicly available trial information.